PEX14 and Alzheimer disease: In patients with no ADNC, about 25% and 50% of all (PEX14-positive) peroxisomes were catalase-positive in the hippocampus and frontal neocortex, respectively which interestingly also coincides with the hippocampus as starting point in AD.